Legacy of Hope, Birmingham, AL – FDA Inspections

Inspection records and compliance data for Legacy of Hope in Birmingham, Alabama. 5 FDA inspections on record, last inspected March 22, 2022.

Company Profile

This profile covers Legacy of Hope based in Birmingham, Alabama, United States.

FDA Inspection History

FDA inspections: 5
OAI: 0
VAI: 1
NAI: 4
Form 483s: 0
Warning letters: 0

First inspected July 22, 2011. Last inspected March 22, 2022.

Most cited issue areas

Procedures to meet core CTGP1 inspection
Quality audits performed periodically1 inspection
Risk factors, clinical evidence1 inspection

FDA inspections (5)

Date	Result	FDA center(s)	Insp. #
March 22, 2022	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	1165715
June 13, 2018	NAI	Biologics · Blood and Blood Products	1058061
February 25, 2016	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	961072
May 9, 2012	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	782279
July 22, 2011	VAI	Biologics · Human Cellular, Tissue, and Gene Therapies	737149

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

The Tombigbee Healthcare Authority

Children's Hospital of Alabama Blood Bank

Southern Blood Services, Inc

International Bioresources Plasma Center Huntsville

American Red Cross Blood Services

Cell Therapy Laboratory

Talecris Plasma Resources Inc

Baptist Medical Center South

The Board Of Trustees Of The University Of Alabama

Biostat Inc.